Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells
出版年份 2017 全文链接
标题
Dextran-Catechin inhibits angiogenesis by disrupting copper homeostasis in endothelial cells
作者
关键词
-
出版物
Scientific Reports
Volume 7, Issue 1, Pages -
出版商
Springer Nature
发表日期
2017-08-03
DOI
10.1038/s41598-017-07452-w
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dextran-Catechin: An anticancer chemically-modified natural compound targeting copper that attenuates neuroblastoma growth
- (2016) Orazio Vittorio et al. Oncotarget
- Endothelial Antioxidant-1: a Key Mediator of Copper-dependent Wound Healing in vivo
- (2016) Archita Das et al. Scientific Reports
- Copper Transport Protein Antioxidant-1 Promotes Inflammatory Neovascularization via Chaperone and Transcription Factor Function
- (2015) Gin-Fu Chen et al. Scientific Reports
- Anti-angiogenic therapy for cancer: current progress, unresolved questions and future directions
- (2014) Naveen S. Vasudev et al. ANGIOGENESIS
- Tetrathiomolybdate-associated copper depletion decreases circulating endothelial progenitor cells in women with breast cancer at high risk of relapse
- (2013) S. Jain et al. ANNALS OF ONCOLOGY
- Characterization of a monoclonal antibody capable of reliably quantifying expression of Human Copper Transporter 1 (hCTR1)
- (2013) Jacob F. Quail et al. JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY
- CTR1 Silencing Inhibits Angiogenesis by Limiting Copper Entry into Endothelial Cells
- (2013) Gomathy Narayanan et al. PLoS One
- Anti-VEGF/VEGFR Therapy for Cancer: Reassessing the Target
- (2012) B. Sitohy et al. CANCER RESEARCH
- Dextran-Catechin Conjugate: A Potential Treatment Against the Pancreatic Ductal Adenocarcinoma
- (2012) Orazio Vittorio et al. PHARMACEUTICAL RESEARCH
- Copper stimulates growth of human umbilical vein endothelial cells in a vascular endothelial growth factor-independent pathway
- (2011) Shun Li et al. EXPERIMENTAL BIOLOGY AND MEDICINE
- Bioinorganic aspects of angiogenesis
- (2010) Luca Domenico D'Andrea et al. DALTON TRANSACTIONS
- The significance of copper chelators in clinical and experimental application
- (2010) Xueqin Ding et al. JOURNAL OF NUTRITIONAL BIOCHEMISTRY
- Cancer Chemoprevention by Natural Products: How Far Have We Come?
- (2010) Rajendra G. Mehta et al. PHARMACEUTICAL RESEARCH
- VEGF-dependent tumor angiogenesis requires inverse and reciprocal regulation of VEGFR1 and VEGFR2
- (2009) Z Zhang et al. CELL DEATH AND DIFFERENTIATION
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine: a phase I/II clinical trial
- (2008) M de Lima et al. BONE MARROW TRANSPLANTATION
- Elevated copper and oxidative stress in cancer cells as a target for cancer treatment
- (2008) Anshul Gupte et al. CANCER TREATMENT REVIEWS
- Novel Role of Antioxidant-1 (Atox1) as a Copper-dependent Transcription Factor Involved in Cell Proliferation
- (2008) Shinichi Itoh et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now